2014
The Immune System and Electroconvulsive Therapy for Depression
Guloksuz S, Rutten B, Arts B, van Os J, Kenis G. The Immune System and Electroconvulsive Therapy for Depression. Journal Of Ect 2014, 30: 132-137. PMID: 24755720, DOI: 10.1097/yct.0000000000000127.Peer-Reviewed Original ResearchConceptsEffects of ECTElectroconvulsive therapyImmune systemMechanism of actionImmune activationImmune functioningImpact of ECTTherapeutic actionTreatment-resistant depressionTransient immune activationPubMed/MEDLINEPossible roleImmunological changesCytokine concentrationsAdrenal axisTreatment optionsLarger sample sizeTreatment resultsPsychiatric conditionsSingle sessionRelevant articlesDefinitive conclusionsSearch termsSample sizeDepression
2011
P02-557 - Electroconvulsive therapy treated patients’ and their relatives’ attitudes toward electroconvulsive therapy
Saran O, Celik S, Guloksuz S, Cakmak D. P02-557 - Electroconvulsive therapy treated patients’ and their relatives’ attitudes toward electroconvulsive therapy. European Psychiatry 2011, 26: 1153. DOI: 10.1016/s0924-9338(11)72858-9.Peer-Reviewed Original ResearchMini-Mental State ExaminationMental State ExaminationElectroconvulsive therapyMemory problemsSubjective feelingsState ExaminationBakirkoy ResearchNegative viewsSide effectsBenefits of ECTClinical Global Impression ScaleMechanism of ECTOverall perceptionAttitudesPerceptionSubjective side effectsCommon side effectsAttitudes of patientsEffective treatment optionGlobal Impression ScaleImpression ScaleInpatient unitECT sessionsTreatment optionsPsychiatric illness
2010
The treatment of bipolar disorder during pregnancy and the postpartum period.
Gülöksüz S, Akdeniz F, Ince B, Oral E. The treatment of bipolar disorder during pregnancy and the postpartum period. Turkish Journal Of Psychiatry 2010, 21: 155-66. PMID: 20514566, DOI: 10.5080/u6131.Peer-Reviewed Original ResearchConceptsPostpartum periodBipolar disorderPsychotropic medicationsBD patientsOnset of BDRisk of relapseRisk-benefit decisionsNeonatal toxicityPregnant patientsAdverse eventsObstetrical outcomesFetal exposureSafety profileBreast milkPharmacological treatmentPrevent recurrenceTreatment optionsMedication effectsPsychotropic agentsReproductive yearsNeurobehavioral developmentRecurrence increasesPregnancyPatientsMedications